Igor Gregoric
Experienced in Thymectomy

Dr. Igor Gregoric

Transplant Surgery
Wellspring Cardiovascular & Thoracic Surgery PA
6400 Fannin St, 
Houston, TX 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Thymectomy
Wellspring Cardiovascular & Thoracic Surgery PA
6400 Fannin St, 
Houston, TX 
OverviewInsuranceLocationsClinical Research

Overview

Igor Gregoric is a Transplant Surgeon in Houston, Texas. Dr. Gregoric is rated as an Experienced provider by MediFind in Thymectomy. His top areas of expertise are Cardiogenic Shock, Mitral Valve Regurgitation, Ventricular Septal Defects, Heart Transplant, and Aortic Valve Replacement.

His clinical research consists of co-authoring 169 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Thymectomy.

Specialties
Transplant Surgery
Licenses
Specialist in TX
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 3 Less Insurance Carriers -

Locations

Wellspring Cardiovascular & Thoracic Surgery PA
6400 Fannin St, Houston, TX 77030
Other Locations
Office
601 E San Antonio St Ste 204, Victoria, TX 77901

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Tricuspid Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System and Optimal Medical Therapy (OMT) Compared to OMT Alone in Patients With Tricuspid Regurgitation
A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Tricuspid Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System and Optimal Medical Therapy (OMT) Compared to OMT Alone in Patients With Tricuspid Regurgitation
Enrollment Status: Recruiting
Publish Date: September 22, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
Enrollment Status: Active_not_recruiting
Publish Date: July 20, 2025
Intervention Type: Device
Study Phase: Not Applicable
Antiplatelet Removal and HemocompatIbility EventS With the HeartMate 3 Pump IDE Study
Antiplatelet Removal and HemocompatIbility EventS With the HeartMate 3 Pump IDE Study
Enrollment Status: Completed
Publish Date: March 27, 2025
Intervention Type: Drug, Device
Study Phase: Not Applicable
Edwards EVOQUE Eos Mitral Valve Replacement: Investigation of Safety and Performance After Mitral Valve Replacement With Transcatheter Device (MISCEND)
Edwards EVOQUE Eos Mitral Valve Replacement: Investigation of Safety and Performance After Mitral Valve Replacement With Transcatheter Device (MISCEND)
Enrollment Status: Active_not_recruiting
Publish Date: November 27, 2024
Intervention Type: Device
Study Phase: Not Applicable
Annular ReduCtion for Transcatheter Treatment of Insufficient Mitral ValvE (ACTIVE): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Assess Transcatheter Mitral Valve Repair With Edwards Cardioband System and GDMT vs GDMT Alone in Patients With FMR and Heart Failure
Annular ReduCtion for Transcatheter Treatment of Insufficient Mitral ValvE (ACTIVE): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Assess Transcatheter Mitral Valve Repair With Edwards Cardioband System and GDMT vs GDMT Alone in Patients With FMR and Heart Failure
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Device
Study Phase: Not Applicable
Multi-Center Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3™ Continued Access Protocol: Post-Approval Continued Follow-up
Multi-Center Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3™ Continued Access Protocol: Post-Approval Continued Follow-up
Enrollment Status: Completed
Publish Date: June 27, 2022
Intervention Type: Device
Study Phase: Not Applicable
SynCardia 50cc Temporary Total Artificial Heart (TAH-t) as a Bridge to Transplant
SynCardia 50cc Temporary Total Artificial Heart (TAH-t) as a Bridge to Transplant
Enrollment Status: Terminated
Publish Date: August 10, 2020
Intervention Type: Device
Study Phase: Not Applicable
A Prospective, Randomized, Multicenter Clinical Trial to Evaluate the Safety and Efficacy of the HeartAssist 5® VAD System Compared to the Thoratec HeartMate II® VAD and HeartWare® HVAD for Left Ventricular Support in Patients Awaiting Cardiac Transplantation
A Prospective, Randomized, Multicenter Clinical Trial to Evaluate the Safety and Efficacy of the HeartAssist 5® VAD System Compared to the Thoratec HeartMate II® VAD and HeartWare® HVAD for Left Ventricular Support in Patients Awaiting Cardiac Transplantation
Enrollment Status: Terminated
Publish Date: July 18, 2018
Intervention Type: Device
Study Phase: Not Applicable
View 7 Less Clinical Trials

169 Total Publications

Comparison of Short versus Extended Valganciclovir Prophylaxis in Donor-Positive Recipient-Negative Mismatched Heart Transplant Recipients: An Observational Study.
Comparison of Short versus Extended Valganciclovir Prophylaxis in Donor-Positive Recipient-Negative Mismatched Heart Transplant Recipients: An Observational Study.
Journal: Clinical transplantation
Published: March 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gregoric's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 30 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile